CSIMarket Company Name, Ticker, Suppliers, else..


Kymera Therapeutics Inc   (KYMR)
Other Ticker:  
 

Kymera Therapeutics Inc

KYMR's Fundamental analysis



Looking into Kymera Therapeutics Inc growth rates, revenue grew by 71.62 % in II. Quarter 2023 from the same quarter a year ago. Ranking at No. 410

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -12.85 %



• More on KYMR's Growth


Kymera Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 9.67 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 21.7.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.03.


• More on KYMR's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 7.47

Kymera Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 9.67 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 21.7.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.03.

Kymera Therapeutics Inc Price to Book Ratio is at 2.34 lower than Indusry Avg. of 611.66. and lower than S&P 500 Avg. of 1171.69

• More on KYMR's Valuation

•  Market Capitalization (Millions $) 1,021
•  Shares Outstanding (Millions) 58
•  Employees -
•  Revenues (TTM) (Millions $) 47
•  Net Income (TTM) (Millions $) -163
•  Cash Flow (TTM) (Millions $) 106
•  Capital Exp. (TTM) (Millions $) -17
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 7.47

•  Market Capitalization (Millions $) 1,021
•  Shares Outstanding (Millions) 58
•  Employees -
•  Revenues (TTM) (Millions $) 47
•  Net Income (TTM) (Millions $) -163
•  Cash Flow (TTM) (Millions $) 106
•  Capital Exp. (TTM) (Millions $) -17





  Ratio
•   Capital Ratio (MRQ) 14.54
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.06
•  Asset Turnover Ratio (TTM) 0.09
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com